Division of Pharmaceutical Evaluation & Policy
Office of Alcohol and Drug Abuse Prevention (OADAP) Professor
Division
Pharmaceutical Evaluation & Policy
Corey Hayes, Pharm.D., Ph.D., MPH, serves as a tenured associate professor in the Department of Pharmacy Practice in the University of Arkansas for Medical Sciences (UAMS) College of Pharmacy, with secondary appointments in the departments of Biomedical Informatics and Psychiatry in the UAMS College of Medicine. He holds the Office of Alcohol and Drug Abuse Prevention Professorship at UAMS. Hayes also serves as a research health scientist with the Central Arkansas Veterans Healthcare System’s Center for Mental Healthcare & Outcomes Research and as deputy director of the Health Resources and Services Administration-funded Rural Telehealth Evaluation Center.
An Arkansas native, Hayes received his Bachelor of Science degree in chemistry from Southern Arkansas University in Magnolia in 2009. In 2013, he received his Doctor of Pharmacy degree from the UAMS College of Pharmacy and a Master in Public Health degree with an emphasis in epidemiology from the Fay W. Boozman College of Public Health. From 2013-2016, he practiced as a clinical pharmacist at Baptist Health Medical Center in Little Rock. In 2016, he returned to UAMS for additional training, completing a National Institute on Drug Abuse-funded T32 Post-Doctoral Fellowship in translational addiction research and a doctorate in pharmaceutical sciences with an emphasis in pharmacoepidemiology. He began his career as an assistant professor in the Center for Health Services Research in the Department of Psychiatry of the UAMS College of Medicine and as an investigator with the Center for Mental Healthcare and Outcomes Research (CeMHoR), which is a national Center of Innovation housed at the Central Arkansas Veterans Healthcare System (CAVHS).
Hayes’ research goal is to leverage data to improve the prevention and treatment of substance use disorders by generating clinically actionable knowledge that informs clinical practice and improves care and policy. His work focuses on improving policies related to opioid prescribing and developing technology-based interventions for improving treatment of patients with opioid use disorder. He has received research funding through the National Institute on Drug Abuse, the Veterans Health Administration, the U.S. Food and Drug Administration, the Centers for Disease Control and Prevention (CDC), the U.S. Department of Justice, the Substance Abuse and Mental Health Services Administration, the U.S. Department of Health and Human Services’ Health Resources and Services Administration, and other foundation sources.
Hayes has co-authored more than 70 scientific articles in leading health care journals, such as Addiction, the American Journal of Public Health, the Morbidity and Mortality Weekly Report, and JAMA Network Open. His research has been highlighted in more than 250 articles from top news outlets, such as The New York Times, USA Today, U.S. News & World Report, NPR and ABC News. His findings have also been used in the development of over six clinical guidelines related to opioid use, including the CDC’s Clinical Practice Guideline for Prescribing Opioids for Pain, and guidelines on opioid and benzodiazepine use from the National Academy of Medicine. His findings have also been used in more than seven national and international policy-related materials issued by the Centers for Medicare and Medicaid Services, the CDC, Urban Institute, the U.S. Joint Economic Committee and the Canadian Agency for Drugs and Technologies in Health among others.
Education and Training
- PharmD–2013
- MPH, Epidemiology–2013
- PhD–2018
- NIDA T32 Post-Doctoral Fellowship in Addiction–2018
Research and Scholarly Interests
I am an Associate Professor with Tenure in the Departments of Pharmacy Practice (primary), Biomedical Informatics (secondary) and Psychiatry (secondary) at the University of Arkansas for Medical Sciences (UAMS). At UAMS, I serve as the Office of Alcohol and Drug Abuse Prevention (OADAP) Professor and Deputy Director of the HRSA-funded Rural Telehealth Evaluation Center. I also have a joint appointment with the VA where I am a Research Health Scientist and Clinical Pharmacist at the VA HSR (COIN) Center for Mental Healthcare and Outcomes Research (CeMHOR) at the Central Arkansas Veterans Healthcare System in Little Rock, Arkansas. My overarching research goal is to improve the prevention and treatment of substance use disorders by generating clinically actionable knowledge from “big data” that informs clinical practice and improves care and policy. I have published >50 peer-reviewed papers in this topic area. I have also been a PI and Co-I of several federally funded studies using secondary data sources including NIH, VA, and HRSA. Currently, I have a VA HSR Career Development Award-2 to develop a predictive model for buprenorphine discontinuation among veterans; adapting the predictive model into a clinical decision support tool using feedback derived from qualitative interviews with providers, operational partners, and veterans; and piloting the clinical decision support tool among waivered providers in hopes of improving veteran retention on buprenorphine (20-231). I also currently leading the NIDA CTN-0142 protocol to rapidly and cost-effectively identify Veteran characteristics that may give insight into personalizing MOUD care at the individual Veteran level. I am also a licensed clinical pharmacist with experience in treating adults with mental health and substance use disorders, having worked on the inpatient team for the psychiatric intensive care units at a local, large, non-profit hospital.